← All companies

ACON

Aclarion, Inc.

ACONW Nasdaq Services-Medical Laboratories EDGAR ↗

$0.03

+0.01 +34.98%

Key statistics

from XBRL data in SEC filings

Market cap

$80.8K

Revenue (TTM)

$77.9K

Net income (TTM)

-$8.05M

EPS (TTM)

$-5.63

P/E ratio

—

Dividend yield

—

Free cash flow

-$7.19M

Cash

$19.0M

Total assets

$20.6M

Gross margin

19.3%

52-week range

$0.02 – $0.03

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Other events Apr 22, 2026 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Other events Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Mar 18, 2026 8-K Regulation FD disclosure Jan 13, 2026 8-K Entered a material agreement Jan 9, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement Oct 14, 2025 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Shareholder vote results Jul 21, 2025 8-K Shareholder vote results; Regulation FD disclosure Jul 7, 2025 8-K Director or officer change Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Regulation FD disclosure Apr 23, 2025 10-K Fiscal year ended 2024-12-31 Apr 9, 2025 8-K Modified rights of security holders; Amended charter or bylaws Mar 28, 2025 8-K Other events Mar 13, 2025 8-K Shareholder vote results Mar 6, 2025 8-K Shareholder vote results; Regulation FD disclosure Feb 28, 2025 8-K Entered a material agreement; Regulation FD disclosure Jan 31, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jan 30, 2025 8-K Entered a material agreement Jan 17, 2025 8-K Entered a material agreement; Regulation FD disclosure Jan 6, 2025 8-K Terminated a material agreement Jan 3, 2025 8-K Shareholder vote results Jan 3, 2025 8-K Entered a material agreement; Unregistered sale of equity Nov 27, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Delisting notice or listing-rule failure Oct 11, 2024 8-K Entered a material agreement; Unregistered sale of equity Oct 1, 2024 8-K Entered a material agreement Sep 24, 2024 8-K Shareholder vote results Sep 23, 2024 8-K Entered a material agreement; Unregistered sale of equity Aug 29, 2024 8-K Delisting notice or listing-rule failure Aug 23, 2024 8-K Entered a material agreement; Unregistered sale of equity Aug 16, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K/A Entered a material agreement Aug 13, 2024 8-K Entered a material agreement Aug 12, 2024 8-K Entered a material agreement Jun 26, 2024